Goodwin Procter LLP advised Caresyntax on the deal. Caresyntax announced the completion of its $100 million Series C funding round led by PFM Health Sciences LP, and...
Caresyntax’s $100 Million Series C Funding Round
LUMICKS Technologies’ $93M Series D Financing
Goodwin Procter LLP and Loyens & Loeff advised Lauxera Capital Partners on the deal, while NautaDutilh assisted LUMICKS Technologies B.V. Lauxera Capital Partners announced their investment...
Lauxera Capital Partners’ Investment in LUMICKS
Goodwin Procter LLP advised Lauxera Capital Partners on the deal. Lauxera Capital Partners announced their investment in LUMICKS as part of a $93 million Series D Financing....
Brighton Park Capital’s $125 Million Growth Investment in OPSWAT
Goodwin Procter LLP advised OPSWAT, Paul, Weiss advised Brighton Park Capital on the deal. OPSWAT announced its $125 million growth investment from Brighton Park Capital. OPSWAT plans...
Kosy Software Ltd’s Seed Financing Round
Goodwin Procter LLP advised Kosy Software Ltd on the deal. Kosy Software Ltd announced its seed financing round led by Picus Capital GmbH. Kosy is an...